The Silver Ink

Saturday, January 16, 2021
Log in
  • United States & World
  • Techie
  • Business & Company News
  • Discovery
  • Lifestyle

Pages

  • About The Silver Ink
  • Advertising
  • Contact US
  • Investor Relations
  • Our Team
  • Privacy Policy GDPR
  • Sec Disclosure
  • Terms of Use

Recent Posts

  • David The Puzzle Man Butler Uses His Newfound Hobby to Help Community June 29, 2018
  • Diamond Thief Arrested in Chicago Days After Stealing $133,000 Worth of Precious Stones June 29, 2018
  • Colorado Goth Metal Band Founder Stabs Homeless Person to Death in Back Alley June 28, 2018
  • Irate South Carolina Woman Cusses Out Black Teens at Pool, Assaults Sheriff’s Deputy June 27, 2018
  • Georgia Couple Arrested For Keeping Mentally Challenged Daughter Locked Inside Room for Months June 27, 2018
  • Washington Man Paralyzed After Run-in With Gun-Toting Carjacker June 26, 2018
  • Autistic Boy Admitted to Emergency Room After Being Impaled By A Plank of Wood June 25, 2018

Shkreli is No Longer the CEO of Turing Pharmaceuticals

December 19, 2015 By Dave Smith Leave a Comment

"apothecary bottles"

Even if some of these drugs save countless lives, in the pharmaceutical business, money is still the prime element and focus.

Following his arrest on charges of fraud, Martin Shkreli is no longer the CEO of Turing Pharmaceuticals. The infamous man behind the 5000% price hike of the life-saving drug Daraprim was taken into custody in New York following security fraud charges related to previously owned hedge funds and Retrophin Inc. drug company.

Even though Martin Shkreli has become the perfect image of everything wrong with the current pharmaceutical market, his move of finding old drugs, buying the production company, and hiking prices, is not a new one. In fact, more and more companies are starting to view this as a viable strategy.

The company Valeant has made a similar moved under the guidance of its CEO, Mike Pearson, earlier this year. After attaining the ownership of two heart-related drugs, named Isuprel and Nitropress, the company raised their price by 525% and 212% respectively. Even though this pales in comparisons to Shkreli’s hike from $13.50 a pill to a staggering $750, it still hints at the birth of a growing trend.

In order to distance his public image from Turing’s as of now former CEO, Martin Shkreli, Pearson claimed that his company does not support a comparison to the aforementioned company due to the fact that it is not reliant on the production of a single drug. After a steady increase in criticisms towards the company, the CEO of Valeant stated that this type of business practice will not become a common one. Even so, he still criticized Big Pharma companies’ direction towards increased funds for research instead of focusing on drug profitability.

Rodelis is another example of this trend, boosting prices for a tuberculosis treatment from $20 to $360. The company claimed that by September it would release the rights for the drug in question, using the profits gained for medicine research along the line. Following a public outcry, the company kept its word and released the drug rights to the non-profit Purdue Research Foundation.

Another older example is the Questcor Pharmaceuticals fiasco that took place between 2005 and 2008. Claiming that it was simply attempting to make the H.P. Acthar drug profitable once again, the company hiked prices by almost 2900%, raising it from $1.235 per vial to the incredibly hefty sum of $29.086. The CEO behind this move, Mallinckrodt, said that this hike was in terms with inflation, be it on the line or below it, even if the public outcry stated otherwise.

Both Valeant and Turing came under the fire of the Pharmaceutical Research and Manufacturers of America lobby group which claimed that the two companies’ business practices were more akin to a hedge fund, not a real and innovative drug company. Turing claimed that their price hike was something common in the drug market while Valeant said that research and development are deemed moot when compared to the amount of drugs brought to the market.

Even if Martin Shkreli is no longer the CEO of Turing Pharmaceuticals, a survey released by the DRX unit of Connecture Inc. showed that from 21.000 types of drugs, almost 3.600 have doubled their price, some of them suffering an even greater increase, since 2007. This is extremely unfortunate, considering that most of these drugs are related to chemotherapy or other life-saving treatments. Some people think that people like Martin Shkreli and Mike Pearson should be brought to justice when they decide to adopt a business strategy that is extremely detrimental to the general public.

Image source:www.pixabay.com

Filed Under: Business & Company Tagged With: Big Pharma, Daraprim drug, Mike Pearson, Nitropress and Isuprel, Purdue Research Foundation, Questcor Pharmaceuticals, Shkreli is No Longer the CEO of Turing Pharmaceuticals, Valeant drug company

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 24 other subscribers

first humans who arrived in North America

First Humans Arrived In North America 10000 Years Earlier

January 17, 2017 By Dave Smith Leave a Comment

gold coin

Rare Gold Coin Found In a Toy Pirate Treasure

October 27, 2016 By Kyle Mills Leave a Comment

clothing material

Air conditioning could be replaced with clothing material that keeps you cool

September 2, 2016 By Carrie Davis Leave a Comment

proxima centauri star

Scientific Breakthrough – Habitable Planet near Proxima Centauri

August 27, 2016 By Dave Smith Leave a Comment

USS independence

Deep Sea Exploration Of World War II Vessel

August 23, 2016 By Dave Smith Leave a Comment

statue of Zeus

Ancient Zeus Sacrifice Skeleton Found In Greece

August 12, 2016 By Dave Smith Leave a Comment

white robot

Robot Exoskeleton Could Improve Life Of The Disabled

August 11, 2016 By Dave Smith Leave a Comment

Bird Fossil Holds Answers to Life After Dinosaurs

October 30, 2015 By Dave Smith Leave a Comment

Polar Bears Are Slowly Dying Due to Climate Change

September 17, 2015 By Stephanie James Leave a Comment

Study Shows Birds Also Fall in Love

September 15, 2015 By Jeff Suchon Leave a Comment

Man-made Climate Change Produces the Highest Temperatures Ever

September 14, 2015 By Dave Smith Leave a Comment

Researchers Discover Why Sweetgrass Is An Efficient Insect Repellent

August 19, 2015 By Jeff Suchon Leave a Comment

The Drinkable Book Could Be The Easiest Way To Clean Water

August 18, 2015 By Jeff Suchon Leave a Comment

Study Reveals Venomous Frogs Are More Dangerous Than Pit Vipers

August 8, 2015 By Kyle Mills Leave a Comment

Categories

  • Automotive & Aviation Industry
  • Business & Company
  • Capital Markets
  • Discovery
  • entertainment
  • Health
  • IT & Diversified Sector
  • Lifestyle
  • Nature
  • Science
  • Techie
  • Uncategorized
  • United States & World
  • World

Copyright © 2021 thesilverink.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.